Facet Turbuhaler 80:4,5 µg/dose & 160:4,5 µg/dose Inhaler
PDF Leaflet Revision Date: 19 July 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of asthma and COPD.
Dosage (summary)
Adults: 1-2 inhalations twice daily; up to 12 inhalations daily as needed.
Onset of Action / Duration
Onset: 1-3 mins, Duration: at least 12 hours
Special Populations
- Elderly
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Safety not established; avoid breastfeeding.
Key Drug Interactions
- CYP3A4 inhibitors
- Beta-adrenergic blockers
Contraindications
- Hypersensitivity to ingredients
- Children <12 years
Common side effects
- Palpitations
- Tremor
- Headache
- Coughing
- Hoarseness
Counselling Points
- Rinse mouth after use
- Use as needed for symptoms
- Do not exceed prescribed dose
Serious warnings
- Risk of pneumonia in COPD
- Adrenal insufficiency risk with abrupt withdrawal
Important Disclaimer
The Facet Turbuhaler 80:4,5 µg/dose & 160:4,5 µg/dose Inhaler professional information leaflet below is the property of Astrazeneca Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
